Showing results (551-560 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|September 22, 2005
Physiological modeling for indirect evaluation of drug tissular pharmacokinetics under non-steady-state conditions: an example of antimicrobial prophylaxis during liver surgeryFranck Lagneau, Jean Marty, Pascale Beyne, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 29, 2006
Percutaneous penetration of methyl nicotinate from ointments using the laser Doppler technique: bioequivalence and enhancer effectsYvonne Remane, Claudia S Leopold, Howard I MaibachJournal of Pharmacokinetics and Pharmacodynamics|April 21, 2006
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatmentsNicholas H G Holford, Phylinda L S Chan, John G Nutt, et al.Journal of Pharmacokinetics and Pharmacodynamics|December 7, 2007
Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patientsMatthew M Hutmacher, Sriram Krishnaswami, Kenneth G KowalskiJournal of Pharmacokinetics and Pharmacodynamics|May 5, 2025
Leveraging large language models to compare perspectives on integrating QSP and AI/MLIoannis P Androulakis, Limei Cheng, Carolyn R Cho, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 5, 2025
A translational physiologically-based pharmacokinetic model for MMAE-based antibody-drug conjugatesHsuan-Ping Chang, Dhaval K ShahJournal of Pharmacokinetics and Pharmacodynamics|March 28, 2025
Information-theoretic evaluation of covariate distributions modelsNiklas Hartung, Aleksandra KhatovaJournal of Pharmacokinetics and Pharmacodynamics|April 11, 2013
Coupled solutions of one- and two-compartment pharmacokinetic models with first-order absorptionN Asmanova, G Koloskov, A I IlinJournal of Pharmacokinetics and Pharmacodynamics|February 20, 2013
D optimal designs for three Poisson dose-response modelsAlan Maloney, Ulrika S H Simonsson, Marloes SchaddeleeJournal of Pharmacokinetics and Pharmacodynamics|July 12, 2013
Model based design and analysis of phase II HIV-1 trialsDinko Rekić, Daniel Röshammar, Ulrika S H SimonssonPageof 107